This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.
Apparently, some vets are already using GLP-1s for diabetic cats. We are all a clinical trial or two away from “Ozempets” becoming mainstream. But do we really want our pets to shun the treats we give them? Tips and pet thoughts here: bob.herman@statnews.com.
The crushing weight of drugs, especially GLP-1s
For the past two-plus years, health insurers have been up to their necks in medical claims. Prices are higher. People are seeing their doctors more. All types of care are elevated, which is thinning insurers’ profit margins.
Continue to STAT+ to read the full story…
